MetaCap

Biomerica Statistics

NASDAQ: BMRAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

1.08-0.01 (-0.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Biomerica by the numbers

Biomerica has a market capitalization of $5.0 million based on 4.60M shares outstanding. With trailing EPS of $-1.64, Biomerica is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 42.3% below its 50-day average and 45.2% below its 200-day average.

Average daily trading volume is 72.95K shares, or about $78,787 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BMRA valuation vs. peer median

BMRA compared with the median of 8 peer companies
MetricBMRAPeer medianDifference
Market cap$4.97M$5.46M-9%
Avg. volume72.95K195.12K-63%

Peer median across 8 companies: TRIB, CDIO, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.

Valuation

Price / sales (latest FY)
1.12
EPS (TTM)
$-1.64

Price and trading

Previous close
1.09
Open
1.13
Day range
1.06 – 1.13
52-week range
1.01 – 2.94
52-week change
-51.57%
Beta
—
Volume
5.38K

Dividends and events

Annual dividend
None
Next earnings date
Aug 26, 2025

Additional statistics

Market Cap
4.97M
Forward Pe
2.77
Eps
-1.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.94
Week52 Low
1.01
Avg Volume
72,951.00
Shares Outstanding
4.60M
Ma50
1.87
Ma200
1.97
Earnings Date
Aug 26, 2025
Pct From52w High
-63.27%
Pct From52w Low
6.93%

Related